| Name | Title | Contact Details |
|---|
Oxford Pharmaceutical Resources is a Totowa, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AMDR is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Neuroptix Corporation is a Acton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Xanitos is a management company that provides hospital housekeeping, patient transport, and central laundries services. It is differentiated by its patented XRO System for cleaning patient rooms, its outstanding operations management team, and by being a private company whose priority is giving top quality service, believing that by so doing, profits will follow. Graeme Crothall, founder and CEO, has 45 years’ experience in hospital housekeeping and during that time he has founded and led four successful companies in the industry whose revenues today exceed $2.5 billion. In 2008 Graeme founded Xanitos by acquiring two small companies, one of which owned the XRO patient room cleaning system, and continuing his track-record of providing top quality service, attracting and holding excellent operations management, and always growing the companies he leads. Xanitos continues to grow because of its patented XRO System for cleaning patient rooms, its outstanding operations management team, and by being a private company whose priority is giving top quality service.
IlluminOss Medical is a privately-held, commercial stage medical device company focused on designing, developing and marketing orthopedic fracture repair products that leverage its proprietary bone stabilization technology, IlluminOss System. This minimally invasive technology allows for fracture fixation through patient specific intramedullary implants. The IlluminOss System utilizes a light-curable polymer, contained within an expandable balloon catheter to achieve bone stabilization. The revolutionary procedure is made through a small percutaneous surgical approach providing patients and clinicians with a fast, patient-specific, method of orthopedic bone stabilization. The company currently markets its products in the EU under a CE Mark for approved clinical applications through both a direct sales force and distribution networks. Founded in 2007, IlluminOss is headquartered in East Providence, RI, and funded by Flare Capital Partners, New Leaf Venture Partners, Tekla Capital, Life Sciences Partners, SR One, Longwood Fund, Excel Venture Management, Pappas Ventures, Mieza Capital and Slater Technology.